trending Market Intelligence /marketintelligence/en/news-insights/trending/JLQY6H1cUyk8TugU943Irw2 content esgSubNav
In This List

Regulus Therapeutics appoints director

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Regulus Therapeutics appoints director

Regulus Therapeutics Inc. said Pascale Witz was elected to the board at the company's June 1 annual stockholders meeting.

Most recently, she served as executive vice president, diabetes and cardiovascular, for Sanofi.